Dr. Amanda Buchanan
Urologist
2 Podcasts on BackTable
Dr. Amanda Buchanan is Division Chief of Pediatric Urology at the University of Kentucky.
Learn from the experiences and expertise of Dr. Amanda Buchanan and other leading voices in your specialty on the BackTable app.
Episode # 233 • 19 May 2025
Multidisciplinary Approaches to Pediatric Urologic Cancer Care
How can pediatric and adult urologists team up to tackle complex cancer cases? In this episode of the BackTable Urology, host Dr. Amanda Buchanan, Division Chief of Pediatric Urology at the University of Kentucky, is joined by her colleagues Dr. Patrick Hensley, an adult urologic oncologist, and Dave Rodeberg, Division Chief of Pediatric Surgery. Their discussion centers around the importance of professional collaboration in urologic oncology care in order to improve patient outcomes.
More from Dr. Amanda Buchanan
Loading recent podcasts…
About
Amanda Buchanan received her medical degree from Tulane University in New Orleans in 2011. She finished her urology residency at the combined Ochsner Clinic and Louisiana State University program in New Orleans in 2016. She then completed her pediatric urology fellowship training in 2018 at the University of Colorado in Denver.
Dr. Buchanan offers the full breadth of pediatric urology management to her patients, including treatment for hypospadias, undescended testicles, hernias/hydroceles, vesiculo-ureteral reflux, ureteropelvic junction obstruction, hydronephrosis, etc. She also offers minimally invasive laparoscopic and robotic surgery to her patients.
Dr. Buchanan’s clinical interests include pediatric urology and pediatric urologic oncology. She is specifically skilled in pediatric, adolescent and young adult urologic oncology, including management of adrenal, renal (Wilms tumor, renal cell carcinoma, angiomyolipoma), testicular/genital (germ cell tumors), retroperitoneal and pelvic (rhabdomyosarcoma) tumors unique to this population. She is also interested in patients with hereditary cancer syndromes such as von Hippel Lindau, tuberous sclerosis and Birt-Hogg-Dube, among others. Additionally, she will provide oncofertility and survivorship programs to patients affected by any malignancy in childhood as these patients frequently experience late effects related to their cancer therapy.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.